Viatris

Latest news

• Viatris (VTRS) Q2 2026 Earnings Call Transcript (opens in a new tab)

  Fortune · Oct 1, 2026

• Viatris Inc. stock falls Wednesday, underperforms market (opens in a new tab)

  MarketWatch · Sep 30, 2026

• Viatris Inc. (VTRS) Stock Price, News, Quote & History (opens in a new tab)

  Yahoo! Finance Canada · Sep 30, 2026

• Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says (opens in a new tab)

  Moomoo · Sep 30, 2026

• Net income before discontinued operations of Viatris, Inc. – HAN:VIA (opens in a new tab)

  TradingView · Sep 30, 2026

• Viatris named to Forbes' World's Best Employers list for sixth year, highlighting strong workplace culture. (opens in a new tab)

  Pluang · Sep 29, 2026

• Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year (opens in a new tab)

  PR Newswire · Sep 29, 2026

• Viatris stock hits 52-week high at 18.4 USD (opens in a new tab)

  Investing.com · Sep 29, 2026

• Will Japan WAKIX Approval Change Viatris (VTRS) Stock Narrative (opens in a new tab)

  Simply Wall Street · Sep 28, 2026

• Viatris Inc. stock rises Monday, outperforms market (opens in a new tab)

  MarketWatch · Sep 28, 2026

• Is Viatris (VTRS) Cheap On Its Japan WAKIX Approval? (opens in a new tab)

  Simply Wall Street · Sep 27, 2026

• Viatris (VTRS) Q1 2026 Earnings Call Transcript (opens in a new tab)

  Fortune · Sep 26, 2026

• Viatris Inc. (VTRS) stock price, news, quote and history (opens in a new tab)

  Yahoo Finance Singapore · Sep 26, 2026

• Viatris Inc. stock rises Friday, outperforms market (opens in a new tab)

  MarketWatch · Sep 25, 2026

• Viatris sues Novo Nordisk, seeks to market generic Wegovy (opens in a new tab)

  Seeking Alpha · Sep 25, 2026

• Viatris sues Novo Nordisk over generic Wegovy patent dispute (opens in a new tab)

  Yahoo Finance · Sep 25, 2026

• Viatris Appoints Joe Paul Philip to Lead Manufacturing Science and Technology in Three Markets (opens in a new tab)

  konsulteer.com · Sep 25, 2026

• Is Viatris Stock Outperforming the S&P 500? (opens in a new tab)

  Yahoo Finance · Sep 24, 2026

• How Viatris Inc. (VTRS) Affects Rotational Strategy Timing (opens in a new tab)

  Stock Traders Daily · Sep 24, 2026

• Viatris (VTRS) Short Interest & Short Float | Updated Sep 2026 $VTRS (opens in a new tab)

  marketbeat.com · Sep 24, 2026

• Oppenheimer Says Viatris Looks Mispriced As Just A Generics Play (opens in a new tab)

  Finimize · Sep 23, 2026

• Viatris Price Target Announced at $25.00/Share by Oppenheimer (opens in a new tab)

  Moomoo · Sep 23, 2026

• Oppenheimer initiates Viatris stock with outperform rating (opens in a new tab)

  Investing.com · Sep 23, 2026

• Oppenheimer Initiates Viatris at Outperform With $25 Price Target (opens in a new tab)

  Yahoo Finance · Sep 23, 2026

• Viatris (VTRS) Institutional Ownership 2026 $VTRS (opens in a new tab)

  marketbeat.com · Sep 23, 2026

• Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business? (opens in a new tab)

  Yahoo Finance · Sep 20, 2026

• Viatris (VTRS) Gains Japan WAKIX Approval As Fair Value Still Sits Higher (opens in a new tab)

  Simply Wall Street · Sep 19, 2026

• Viatris Stock Price Forecast. Should You Buy VTRS? (opens in a new tab)

  StockInvest.us · Sep 18, 2026

• Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy (opens in a new tab)

  Yahoo · Sep 17, 2026

• Could Japan Sleep Drug Approval Alter The Investment Case For Viatris (VTRS)? (opens in a new tab)

  Simply Wall Street · Sep 16, 2026